AUTOGENOMICS, INC.

Profile

Company Names

AUTOGENOMICS, INC.

Addresses

2980 SCOTT STREET, VISTA, CA 92801

Phone Numbers

(760) 477-2248

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$88,636,233.00

Number of Funding Rounds:

15
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
15
2012-12-27 
$165,600.00 
$165,600.00 
$0.00 
Equity 
14
2010-04-15 
$8,576,800.00 
$8,576,800.00 
$0.00 
 
13
2010-03-09 
$13,125,000.00 
$13,125,000.00 
$0.00 
Debt 
12
2010-02-09 
$1,121,400.00 
$1,121,400.00 
$0.00 
Debt 
11
2010-01-15 
$274,000.00 
$274,000.00 
$0.00 
 
10
2009-07-10 
$10,751,014.00 
$10,751,014.00 
$0.00 
Debt 
9
2009-03-02 
$14,111,640.00 
$14,111,640.00 
$0.00 
Debt 
8
2008-05-05 
$30,000.00 
$30,000.00 
$0.00 
 
7
2007-12-30 
$100,000.00 
$100,000.00 
$0.00 
Equity 
6
2007-12-01 
$11,125,589.00 
$11,125,589.00 
$0.00 
Debt 
5
2007-03-21 
$75,000.00 
$75,000.00 
$0.00 
 
4
2007-02-14 
$6,473,478.00 
$6,473,478.00 
$0.00 
Equity 
3
2006-05-01 
$17,632,595.00 
$18,867,294.00 
$1,234,699.00 
Equity 
2
2005-05-18 
$20,000.00 
$20,000.00 
$0.00 
 
1
2001-11-26 
$5,054,117.00 
$5,054,117.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN 
 
ALLISON 
DIRECTOR
CHARLES 
 
BIRMINGHAM 
DIRECTOR
NANIBHUSHAN 
 
DATTAGUPTA, PH.D. 
EXECUTIVE OFFICER
WILLIAM 
H. 
DAVIDSON, D.B.A. 
DIRECTOR
LAURENCE 
M. 
DEMERS 
DIRECTOR
LAURENCE 
M. 
DEMERS, PH.D. 
DIRECTOR
PATRICK 
 
DILLON 
EXECUTIVE OFFICER
THOMAS 
V. 
HENNESSEY, JR. 
EXECUTIVE OFFICER, DIRECTOR
ERIC 
S. 
KENTOR 
DIRECTOR
FAREED 
 
KURESHY 
EXECUTIVE OFFICER, DIRECTOR
RANDALL 
R. 
LUNN 
DIRECTOR
DONALD 
E. 
POGORZELSKI 
DIRECTOR
SHAILENDRA 
 
SINGH 
EXECUTIVE OFFICER
SHAILENDRA 
 
SINGH, PH.D. 
EXECUTIVE OFFICER
JOSEPH 
P. 
SULLIVAN 
DIRECTOR
THOMAS 
R. 
TESTMAN 
DIRECTOR
RAMANATH 
 
VAIRAVAN 
EXECUTIVE OFFICER
PETER 
 
WILDING 
DIRECTOR
EUGENE 
J. 
ZURLO 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2012-12-27 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
 
2010-04-15 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2007-12-30 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
 
2005-05-18 
D/A
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2006-05-01 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2001-11-26 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
 
2008-05-05 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
 
2007-03-21 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
 
2010-01-15 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Debt 
2007-12-01 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2007-02-14 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Debt 
2010-02-09 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Debt 
2009-07-10 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Debt 
2009-03-02 
D/A
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Debt 
2010-03-09 
D
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Debt 
2010-03-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
JEFFERIES + COMPANY, INC.